pulmonary emboli - Nursing Case Study

Pathophysiology

• Primary mechanism: Thrombus formation, often originating from deep veins in the legs (DVT), travels through the venous system and lodges in the pulmonary arteries, obstructing blood flow to lung tissue.

• Secondary mechanism: Obstruction leads to increased pulmonary vascular resistance and right ventricular strain as the heart works harder to pump blood through narrowed vessels, potentially causing right-sided heart failure.

• Key complication: Impaired gas exchange due to reduced perfusion causes hypoxemia, leading to respiratory distress and, in severe cases, can result in cardiogenic shock or death if not promptly managed.

Patient Profile

Demographics:

62-year-old female, retired high school teacher

History:

• Key past medical history: History of deep vein thrombosis, hypertension, type 2 diabetes, and obesity

• Current medications: Warfarin, Metformin, Lisinopril, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Sudden onset of chest pain and shortness of breath

• Key symptoms: Severe dyspnea, pleuritic chest pain, hemoptysis, dizziness, and palpitations

• Vital signs: Blood pressure 90/60 mmHg, heart rate 130 bpm, respiratory rate 28 breaths per minute, oxygen saturation 82% on room air, temperature 37.8°C

Section 1

As the medical team swiftly initiates the initial assessment of the patient, the complexity of her condition becomes increasingly evident. Upon physical examination, the patient exhibits pronounced jugular venous distention and a new-onset S3 heart sound, indicating possible right-sided heart strain. Her skin is cool and clammy, suggestive of poor perfusion. Given the sudden drop in oxygen saturation to 82% despite supplemental oxygen via a non-rebreather mask, urgent arterial blood gases are obtained. The results reveal severe hypoxemia with a PaO2 of 55 mmHg, accompanied by a respiratory alkalosis (pH 7.49, PaCO2 30 mmHg) due to hyperventilation. Laboratory findings show elevated D-dimer levels, supporting the suspicion of a thrombotic event, while the ECG demonstrates right axis deviation and T-wave inversions in the precordial leads, indicative of right ventricular strain.

The patient's condition rapidly deteriorates as she begins to exhibit signs of cardiogenic shock. Her blood pressure continues to fall, now measuring 80/50 mmHg, despite aggressive fluid resuscitation. The heart rate remains elevated at 140 bpm, and her mental status begins to decline, with increasing confusion and agitation. The medical team decides to perform an urgent CT pulmonary angiogram, which confirms multiple large bilateral pulmonary emboli obstructing major branches of the pulmonary arteries. This critical finding prompts immediate consideration of advanced interventions such as thrombolysis or surgical embolectomy, weighing the risks and benefits given her anticoagulation therapy with warfarin and the potential for bleeding complications.

In parallel, the patient's worsening renal function, evidenced by rising creatinine levels (2.1 mg/dL, up from baseline of 1.0 mg/dL), adds another layer of complexity. This renal impairment raises concerns about the patient's ability to clear medications and the risk of contrast-induced nephropathy from the CT scan. The multidisciplinary team must now deliberate on balancing the urgent need to dissolve the emboli with the potential risks associated with each intervention. The case progresses to a critical juncture, necessitating high-level clinical reasoning to navigate the intertwined challenges of managing acute pulmonary embolism, hemodynamic instability, and evolving organ dysfunction.

Section 2

The medical team decides to proceed with thrombolytic therapy, given the patient's deteriorating condition and the significant burden of the emboli. They administer tissue plasminogen activator (tPA) with close monitoring in the intensive care unit. Within the first hour of treatment, the patient shows some initial improvement; her oxygen saturation increases to 88%, and her heart rate decreases slightly to 120 bpm. However, her blood pressure remains critically low at 85/55 mmHg, prompting the team to initiate a norepinephrine infusion to support her hemodynamic status. Despite these efforts, the patient begins to exhibit signs of acute bleeding, with a sudden drop in hemoglobin from 12 g/dL to 9 g/dL, raising alarms about the risks of continued thrombolytic therapy.

Simultaneously, the patient's renal function worsens, with creatinine levels rising to 2.5 mg/dL, and urine output declining significantly. This raises immediate concerns regarding the patient's fluid status and the potential for acute kidney injury exacerbated by the thrombolytic therapy. The team is now faced with a critical decision: whether to continue with the thrombolytic treatment, which risks further bleeding and renal impairment, or to consider surgical embolectomy, which carries its own set of risks given her current instability. The multidisciplinary team, including cardiology, nephrology, and critical care specialists, convenes to reassess the balance of risks and benefits, focusing on strategies to optimize the patient's perfusion without compromising her renal function further.

As the discussion unfolds, the patient's mental status continues to decline, with fluctuating levels of consciousness and increased agitation. Neurology is consulted to evaluate the possibility of a central nervous system event due to embolic phenomena or intracranial bleeding, adding yet another layer of complexity to her management. This new development necessitates an urgent head CT scan to rule out cerebral complications. The team must now integrate these evolving clinical findings with the immediate need to stabilize the patient, ensuring that each decision is meticulously weighed to navigate the intertwined challenges of her acute pulmonary embolism, hemodynamic instability, and multi-organ dysfunction.

Section 3

As the multidisciplinary team deliberates on the best course of action, the patient's condition takes a sudden turn. The head CT scan reveals no signs of intracranial hemorrhage, offering a momentary sigh of relief. However, it does reveal multiple small embolic strokes, indicating that the embolic burden is more extensive than initially thought. This complicates the clinical picture further, as it suggests the necessity for continued anticoagulation despite the bleeding risks. The neurologist emphasizes the importance of balancing the prevention of further embolic events with the risk of exacerbating the patient's bleeding tendency.

Meanwhile, the patient's hemodynamic status remains precarious. Despite the norepinephrine infusion, her blood pressure remains borderline at 90/60 mmHg, and her heart rate is sustained at 115 bpm. Her lactic acid levels have climbed to 4.5 mmol/L, indicating worsening tissue perfusion. The team decides to initiate a low-dose vasopressin infusion alongside norepinephrine to optimize her blood pressure further. In addition, a cautious approach to fluid resuscitation is undertaken to improve her renal perfusion without overwhelming her compromised cardiovascular system.

Despite these interventions, the patient's renal function continues to decline. Her creatinine levels rise to 3.0 mg/dL, and her urine output diminishes to oliguria, heightening the concern for acute kidney injury. This prompts nephrology to suggest renal replacement therapy as a contingency plan. However, the team remains hesitant, recognizing that the patient's volume status is already tenuous. They agree to closely monitor her renal parameters while reassessing the need for surgical intervention versus continued medical management. As the team grapples with these complex decisions, they must constantly evaluate the potential benefits and drawbacks of each therapeutic option, understanding that the patient's journey is contingent on their ability to adapt to her rapidly changing clinical status.

Section 4

As the team continues to monitor the patient, a new complication surfaces that demands immediate attention. The patient suddenly develops respiratory distress, characterized by labored breathing and a drop in oxygen saturation to 84% on high-flow nasal cannula. An urgent arterial blood gas analysis reveals a pH of 7.28, PaCO2 of 55 mmHg, and PaO2 of 58 mmHg, indicating acute respiratory acidosis superimposed on hypoxemia. The intensivist notes bilateral crackles on auscultation, suggesting worsening pulmonary edema, possibly exacerbated by the fluid resuscitation efforts. A stat chest X-ray is ordered, revealing diffuse bilateral infiltrates consistent with acute respiratory distress syndrome (ARDS).

This development complicates the clinical scenario further, as it necessitates an escalation in respiratory support. The team deliberates the risks and benefits of initiating mechanical ventilation, weighing the potential for ventilator-induced lung injury against the need for adequate oxygenation. Given the patient's fragile hemodynamic status, they opt for a trial of non-invasive positive pressure ventilation (NIPPV) to improve gas exchange while minimizing additional cardiac strain. Meanwhile, a reduction in fluid administration is considered to mitigate the risk of further pulmonary congestion.

As the patient battles this new respiratory challenge, the multidisciplinary team remains vigilant, constantly reassessing her response to the NIPPV and closely monitoring her hemodynamic and renal parameters. The nephrologist reiterates the importance of maintaining a delicate balance between fluid management and renal support, while the intensivist emphasizes the need for regular evaluation of her ventilatory status. Together, they work to navigate the intricacies of her case, understanding that each decision is critical to preventing further deterioration and advancing her recovery.

Section 5

As the NIPPV is initiated, the patient's respiratory status shows a modest improvement, with her oxygen saturation rising to 90% and her respiratory rate stabilizing at 24 breaths per minute. However, the team remains cautious, aware that her progress is fragile. Within a few hours, routine laboratory tests reveal a concerning trend: the patient's serum lactate levels have risen to 4.5 mmol/L, indicative of worsening perfusion and potential tissue hypoxia. Concurrently, her blood pressure begins to fall, with readings dropping to 88/54 mmHg, raising alarms about the adequacy of her circulatory support.

In response, the team conducts a focused assessment to determine the underlying cause of the hypotension. Despite the reduction in fluid administration, the patient exhibits signs of peripheral vasoconstriction and poor capillary refill, suggesting that her hemodynamic instability may be multifactorial. The intensivist considers the possibility of sepsis as a complicating factor, prompting the initiation of broad-spectrum antibiotics while cultures are obtained. The cardiologist, meanwhile, is concerned about the potential contribution of right ventricular strain secondary to the pulmonary emboli, warranting an urgent echocardiogram to evaluate cardiac function.

As these developments unfold, the team faces complex decisions regarding the optimization of the patient's hemodynamic status. Vasoactive support is considered to address her hypotension, but the risk of exacerbating her pulmonary edema and the potential impact on renal function make this a challenging decision. Continuous reassessment of her clinical status, guided by real-time data from invasive monitoring, becomes paramount. Each choice is weighed with the understanding that the patient's path to recovery is contingent upon the careful balancing of these competing priorities.